Inmaculada Ihle-Masip serves as the Head of Marketing at Laboratorios Gebro Pharma, where she leverages nearly two decades of extensive experience in the pharmaceutical industry to drive strategic initiatives and foster brand growth. In her current role, Inmaculada is instrumental in leading a dynamic marketing...
Inmaculada Ihle-Masip serves as the Head of Marketing at Laboratorios Gebro Pharma, where she leverages nearly two decades of extensive experience in the pharmaceutical industry to drive strategic initiatives and foster brand growth. In her current role, Inmaculada is instrumental in leading a dynamic marketing team that focuses on the launch strategies for innovative drugs, branded generics, and hospital products. Her expertise in brand management encompasses positioning, messaging, and the development of comprehensive marketing strategies that resonate with healthcare professionals and patients alike.
Inmaculada's approach is characterized by effective communication and co-creation, ensuring that all stakeholders are aligned and engaged throughout the product lifecycle. She excels in managing cross-functional teams, facilitating collaboration between marketing, sales, and product development to execute strategic business plans and tactical programs that yield measurable results. Her proficiency in agile methodologies allows her to adapt quickly to market changes, ensuring that Gebro Pharma remains at the forefront of industry trends.
A key focus of Inmaculada's work involves market access strategies, particularly in the oncology sector, where she has successfully positioned products to meet the evolving needs of healthcare providers and patients. Her commitment to performance management and team leadership fosters a culture of excellence within her team, driving continuous improvement and innovation. Through her strategic vision and hands-on leadership, Inmaculada Ihle-Masip is not only shaping the future of Gebro Pharma but also contributing to the advancement of healthcare solutions that make a meaningful impact on patients' lives.
